Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study
Analytical Cellular Pathology2021Vol. 2021, pp. 1–10
Citations Over Time
Abstract
High SLC34A2 IHC expression correlated with adverse clinicopathological prognostic parameters. Furthermore, SLC34A2 was identified as an independent factor for DFS that could serve to improve risk stratification of PTC patients for better management.
Related Papers
- → Assessment of Significance of Novel Proteins in Breast Cancer Using Tissue Microarray Technology(2016)4 cited
- → [Development and clinical application of frozen tissue microarray in lung cancer diagnosis.].(2008)1 cited
- Tissue microarrays:a new positive control of immunohistochemical staining(2006)
- Comparative analysis on the expression of tumor marker in soft tissue sarcoma by tissue microarray and by immunohistochemistry(2007)
- Establishment of tissue microarray technique by manual method(2007)